Meilani Syampurnawati

Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL

Mardiah Suci Hardianti, E Tatsumi, Meilani Syampurnawati et al. · Leukemia · 2004 · 66 citations

Tumor Biology, Ongoing Mutation, Lymphoid Neoplasia +7

ACE gene polymorphism and atherosclerotic lesion of carotid artery among offsprings of type 2 diabetes mellitus.

Dyah Purnamasari, Budiman D Widjojo, Dono Antono et al. · PubMed · 2012 · 28 citations

DR negativity is a distinctive feature of M1/M2 AML cases with NPM1 mutation

Meilani Syampurnawati, E Tatsumi, Bambang Ardianto et al. · Leukemia Research · 2008 · 24 citations

Npm1 Mutation, Dr Negativity, Pathology +3

HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression

Meilani Syampurnawati, E Tatsumi, Kaho Furuta et al. · Leukemia Research · 2006 · 17 citations

Histocompatibility, Immunogenetics, Hla-dr-negative Aml +11

Expression of Activation-Induced Cytidine Deaminase (AID) in Burkitt Lymphoma Cells: Rare AID-Negative Cell Lines with the Unmutated Rearranged V_HGene

Mardiah Suci Hardianti, E Tatsumi, Meilani Syampurnawati et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 14 citations